Vaziri N D, Robinson M A, Barton C, Ness R
J Dial. 1978;2(4):393-8. doi: 10.3109/08860227809079325.
Topical thrombin was applied to the cannulation sites during and after withdrawal of the needles. The duration of bleeding was reduced by 50% compared to the control period in patients with various internal arteriovenous communications undergoing maintenance hemodialysis treatment. Accordingly, use of topical thrombin appears effective in saving patients and staffs time, minimizing the blood loss in these anemic patients, and preventing the possible injurious effect of prolonged compression of vascular access to accomplish hemostasis.
在拔针期间及之后，将局部凝血酶应用于插管部位。与接受维持性血液透析治疗的各种体内动静脉分流患者的对照期相比，出血持续时间减少了50%。因此，局部应用凝血酶似乎有效地节省了患者和医护人员的时间，使这些贫血患者的失血量最小化，并防止了为实现止血而长时间压迫血管通路可能产生的有害影响。
